MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — Transgender women who undergo a gender-affirming orchiectomy may have an increased risk for ...

During an orchiectomy, doctors surgically remove one or both testicles. Some transgender women seek this surgery as part of gender affirming care. An orchiectomy can also be part of a broader set of ...

Stage 1 testicular cancer is highly curable, with cure rates exceeding 95%, and is confined to the testicle. Diagnosis involves scrotal ultrasound, tumor marker blood tests, and radical inguinal ...